Janney Montgomery Scott Starts Ionis Pharmaceuticals (IONS) at Buy
- Wall St. touches two-week high on deals, strong earnings
- Unusual 11 Mid-Day Movers 10/24: (UNIS) (MBVT) (ACCO) Higher; (TDW) (INO) (BCC) Lower
- AT&T (T) to Acquire Time Warner (TWX) for $107.50/Share
- Rockwell Collins (COL) to Acquire B/E Aerospace (BEAV) for $6.4B
- TD Ameritrade (AMTD) to Acquire Scottrade in $4B Cash & Stock Deal
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Janney Montgomery Scott initiated coverage on Ionis Pharmaceuticals (NASDAQ: IONS) with a Buy rating and a price target of $47.00.
Shares of Ionis Pharmaceuticals closed at $36.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Seaport Global Securities Starts Union Pacific (UNP) at Buy
- UBS Starts Tabula Rasa Healthcare (TRHC) at Buy
- Citi Starts MedEquities Realty Trust (MRT) at Neutral
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesJanney Montgomery Scott
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!